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Idiopathic dilated cardiomyopathy is a serious cardiac dis- 
order with primary manifestations related to abnormal 
left ventricular systolic perfornrance. Patients predomi- 
nantly have symptoms of left hean failure but may 
also develop right heart failure. arrhythmia and thromba- 
embolism. Among adult padeors. 60 to 7J% are dead at 
5 years after presentation (1.2). Approximately one half 
of deaths are sudden (3). The outcome is worse in subgroups 
of patients with extremely poor left ventricular function 
(1.2). 
Compared with the wealth of cardiovascular literature 
regarding idiopathic dilated cardiomyopathy to adults. there 
are relatively few repaw concerning the clinical character- 
istics of idiopathic dilated cardiomyopathy in pediatnc pa- 
tients KZO years old). Greenwood et al. (4) reported a 30 
year experience in 161 pediatric patients with primary myo- 
cardial disease. On follow-up, approximately one third of the 
patients were dead. one third had recovered and one third 
had chronic symptoms of cardiac disease. Patients with 
myocarditis and restrictive cardiomyopathy were included in 
the study. Other studies either have included very few 
patients (5) or have focused on echocardiographic or patho- 
logic findings (6-8). 
A report from the Mayo Clinic (9) described the clinical 
course of 24 children with idiopathic dilated cardiomyopathy 
and found actoari~i rurvival similar to that reported in adult 
patients (2). The survival rate was 63% at I-year follow-up 
and 34% at 5 years. The repin-t could not define any sensitive 
aed specific clinical predictors of outcao~e, in&ding degree 
of left ventricular dysfunction 81 presentation. A trend for 
worse survival was noted in older patients. Ten (91%) of I I 
patients >2 years of age died on follow-up compared wr:h 5 
(38%) of 13 patients 52 years. 
Factori for outcome in children. The current report by 
Griffin et al. in this issue of the Journal (10) reviews i .n 
recent clmical expenence at the Univenity of Washingtw, 
St. Louir with 32 pediatric patient- with idiopathic dilated 
cardiomyopathy. The significant finding in this study is the 
marked difference in survival based on age. Of 20 patients 
52 years of age at presentation. IO were asjimptomatic on 
follow-up and 5 (25%) died. In contrast. all I2 patients 22 
years oi age died during follow-up. If one combines the 
Mayo Clinic and University of Washingtorr+rz, monrdity 
rare on follow-up in dilated cardiomyopathy is 96% in 
pediatric patients >2 years of age compared with 30% in 
those a2 years. 
Other factors identified by Griffin et al. (IO) in paiients 
wrrh a poor outcome included persrs~ent cardiomegaly on 
follow-up and significant arrhythmia. The specificity of tbs 
latter finding for poor outcome is questionable. however, 
becaure Holler monitoring was not routine in many of the 
younger padents who did well. The inwsligators state that 
patiem were tr ated with current. op!wsl medical manage- 
ment. including vasodilaror therapy in iicent cases. They 
also repon that medical therapy did not appear to change 
prognow. A direct comparison of outcome in those treated 
with and without vascdilator therapy is not presented and 
may be of some interest in view of the rcceo: repons of 
possible improved survival in adult patients with congestive 
heart failure treated with vasodilator therapy (11.12). 
Role ofage in prognosis. The finding by Griffin et al. (10) 
of a pronounced difference in survival based on age in 
children with dilated cardiomyopaihy is impressive aml 
provokes several questions. Could selection bias. which is 
usual in patient care at a rertiary institution (that is. Univer- 
sity of Washiogton), account for why dilated cardioroyopa- 
thy appears to be a much more malignant process in older 
chrldren? Are younger patients (~2 yea old) with less 
serious disease more likely to be referred to tertiary centers 
and is this factor affectin? jbrvival rates? It is undkely that 
selection bias is wwunting for survival ditTewoces because 
there were no age-related ifferences in the degree of severe 
left ventricular dysfunction in patients in both the t’oiversity 
of Washington and the Mayo Clinic series. Do thr survival 
data suggest wo different disease processes in the two age 
groops? The causes of the idiopathic dilated cardiomyopathy 
are uncer!ain, and different age-r&ted causes cannot be 
excluded. A diagnosis of myocarditis is often difficult to 
confirm (13) and perhaps many children ~2 years of age 
diagnosed with idiopathic dilated cardiomyopathy have a 
slowiy resolving myocardilis. The pathologic findings by 
Gritin et al. of endornyocardial Pbroelastosir only in 
younger children may alxl be related to different ctiologic 
mcchanrsms. Irrespective of inciting etiology, host mecha- 
nisms used to combat disease and repair myocardial damage 
may differ in eKectivencss baaed on age. The younger heart 
may be more “plastic” in dealing with myocardial insult 
with subsequent recovery more likely. 
Implications for therapy. As discussed by Griffin et al. 
(IO). their data have practical implications with respect to 
treatment strategies. Older children should be considered 
almost immediately for heart transplanlalion and a longer 
n&d of observauon ar~~rs~: xwded in the younger .I 
children. In fact. survival rater after presentation with 
dilated cardiomyopathy are no worse than reported survival 
rates after cardiac tranrplantalion in patients 52 years old 
(14). 
Cardiac transplantation in children has not yet been 
applied to the same degree as in adults, perhaps because of 
smaller body size. the demands of post-transplant therapy 
and close follow-up and the side effects from prolonged 
suppression of the immune system, including nephrotoxicity 
and hemalolwic malimmncies. However. recent rwxts 
(14.15) do do&ent an increasing ulilizalion of cardiac 
trannplvltation in children with improving results. The re- 
port by Griffin et al. identifies an imporiant subset ofpatients 
with dilated cardiomyopathy whose only chance for long- 
term survival with current therapies may be cardiac trans- 
plantation. 
